Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Germany’s CABB Gets New Private Owner

by Michael McCoy
March 21, 2011 | A version of this story appeared in Volume 89, Issue 12

AXA Private Equity has agreed to sell CABB to Bridgepoint, another private equity firm, for an undisclosed sum. CABB calls itself one of the world’s leading suppliers of chemical building blocks based on chlorine and acetic acid. Since being acquired by AXA in 2007, CABB has made two acquisitions and doubled its annual sales to about $433 million. “Our focus is not financial engineering,” says Christof Namenyi, managing director of AXA Private Equity Deutschland. “We change companies.”

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.